The aim of this study was to assess the leverage of the SARS-CoV-2 pandemic on the diagnostic and therapeutic process of PAH and CTEPH in Poland, including an analysis of the incidence and course of coronavirus infection in the population of patients with PH registered in the BNP-PL national database. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.